Curcumin is one of the most amazing natural medicine that I use every day. Its natural antiinflammatory and I prefer to use it over pharmacological anti-inflammatory drugs because has less side effects. It works the same pathway as the aspirin and ibuprofen in reducing the COX expression being a COX1 and COX2 inhibitor.
In addition, curcumin boost Natural Killer cells activity and help fight infections and blocks NF-kapa B. The anti-cancerous mechanism was studied for the effect on major master switches and cytochromes in the body like: P450, tyrosine kinases, p-53 signaling, glutathione S- Transferase, Cycloxigenase and transcription factors.
Curcumin is antimicrobial, antiviral (reduces transcription of Epstein Barr25 and HIV virus 26, 27), inhibits parasites and protozoa. It offers protection against cardio risk as a natural blood thinner works by reducing cholesterol oxidation, increases HDL30, reducing fibrinogen38 and platelet aggregation. On the other hand, protects and heals the gastro-intestinal track and helps with stomach healing.
Curcumin is for everyone with few exceptions: anyone with gallstones (because enhances bile), anyone on blood thinning medication, (increases the effect of medication) and pregnancy. Best to consult a Physician before usage.
There are many products with curcumin on the market. When choosing a good formula I look for Nutraceuticals with reputation of high standards of extraction, potency and a synergy of right blending in the capsule.
1. Jäger R, Lowery RP, Calvanese AV, Joy JM, Purpura M, Wilson JM. Comparative absorption of curcumin formulations. Nutrition Journal. 2014;13:11.
2. Osawa T, Sugiyama Y, Inayoshi M, Kawakishi S. Antioxidative activity of tetrahydrocurcuminoids. Biosci Biotechnol Biochem. 1995 Sep;59(9):1609-12.
3. Lai CS, Wu JC, Yu SF, Badmaev V, Nagabhushanam K, Ho CT, Pan MH. Tetrahydrocurcumin is more effective than curcumin in preventing azoxymethane-induced colon carcinogenesis. Mol Nutr Food Res. 2011 Dec;55(12):1819-28.
4. Okada K, Wangpoengtrakul C, Tanaka T, Toyokuni S, Uchida K, Osawa T. Curcumin and especially tetrahydrocurcumin ameliorate oxidative stress-induced renal injury in mice. J Nutr. 2001 Aug;131(8):2090-5.
5. Araujo CC, Leon LL.Biological activities of Curcuma longa L. Mem Inst Oswaldo Cruz. 2001 Jul;96(5):723-8.
6. Yadav VS, Mishra KP, Immunomodulatory effects of curcumin. Immunopharmacol Immunotoxicol. 2005;27(3):485-97.
7. Takada Y, Bhardwaj A. Nonsteroidal anti-inflammatory agents differ in their ability to suppress NFkappaB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation. Oncogene. 2004 Dec 9;23(57):9247-58.
8. Swarnakar S, Ganguly K.Curcumin regulates expression and activity of matrix metalloproteinases 9 and 2 during prevention and healing of indomethacin-induced gastric ulcer. J Biol Chem. 2005 Mar 11;280(10):9409-15. Epub 2004 Dec 22.
9. Suzuki M, Nakamura T. Elucidation of anti-allergic activities of curcumin-related compounds with a special reference to their anti-oxidative activities. Biol Pharm Bull. 2005 Aug;28(8):1438-43.
10. Kobayashi T, Hashimoto S Curcumin inhibition of Dermatophagoides farinea-induced interleukin-5 (IL-5) and granulocyte macrophage-colony stimulating factor (GM-CSF) production by lymphocytes from bronchial asthmatics. Biochem Pharmacol. 1997 Oct 1;54(7):819-24.
11. Yamamoto H, Hanada K. Inhibitory effect on curcumin on mammalian phospholipase D activity. FEBS Lett. 1997 Nov 10;417(2):196-8.
12. Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). J Altern Complement Med. 2003 Feb;9(1):161-8.
13. Holt PR, Katz S Curcumin therapy in inflammatory bowel disease: a pilot study. Dig Dis Sci. 2005 Nov;50(11):2191-3.
14. Heck AM, et al. Potential interactions between alternative therapies and warfarin. Am J Health Syst Pharm. Jul2000;57(13):1221-7.
15. Reddy AC, et al. Effect of Dietary Turmeric (Curcuma longa) on Iron-induced Lipid Peroxidation in the Rat Liver. Food Chem Toxicol. Mar1994;32(3):279-83.
16. Subramanian M, et al. Diminution of Singlet Oxygen-induced DNA Damage by Curcumin and Related Antioxidants. Mutat Res. Dec1994;311(2):249-55.
17. Ruby AJ, et al. Anti-tumour and Antioxidant Activity of Natural Curcuminoids. Cancer Lett. Jul1995;94(1):79-83.
18. Ammon HP, et al. Mechanism of Anti-inflammatory Actions of Curcumin and Boswellic Acids. J Ethnopharmacol. 1993;38:113.
19. Deodhar SD, et al. Preliminary Studies on Anti-Rheumatic Activity of Curcumin. Ind J Med Res. 1980;71:632.
20. Xu Y, Ku BS, The effects of curcumin on depressive-like behaviors in mice. Eur J Pharmacol. 2005 Jul 25;518(1):40-6.
21. Yang F, Lim GP. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem. 2005 Feb 18;280(7):5892-901. Epub 2004 Dec 7.
22. Srivastava V, et al. Effect of Curcumin on Platelet Aggregation and Vascular Prostacyclin Synthesis. Arzneim Forsch/Drug Res. 1986;36:715-17.
23. Mehta K, et al. Antiproliferative Effect of Curcumin (Diferuloylmethane) against Human Breast Tumor Cell Line. Anticancer Drugs. Jun1997;8(5):470-81.
24. Rao CV, et al. Chemoprevention of Colon Carcinogenesis by Dietary Curcumin, a Naturally Occurring Plant Phenolic Compound. Cancer Res. Jan1995;55(2):259-66.
25. Ranjan D, et al. The Effect of Curcumin On Human B-Cell Immortalization by Epstein-Barr Virus. Am Surg. Jan1998;64(1):47-51.
26. Mazumder A, et al. Inhibition of Human Immunodefficiency Virus Type-I Integrase by Curcumin. Biochem. Pharmacol. 1995;49(11):1165-70.
27. Barthelemy S, et al. Curcumin and Curcumin Derivatives Inhibit Tat-mediated Transactivation of Type 1 Human Immunodeficiency Virus Long Terminal Repeat. Res Virol. Jan1998;149(1):43-52.
28. Kawamori T, et al. Chemopreventive Effect of Curcumin, A Naturally Occurring Anti-inflammatory Agent, During the Promotion/Progression Stages of Colon Cancer. Cancer Res. Feb1999;59(3):597-601.
29. Hidaka H, Ishiko T, Furuhashi T, Kamohara H, Suzuki S, Miyazaki M, et al. Curcumin inhibits interleukin 8 production and enhances interleukin 8 receptor expression on the cell surface:impact on human pancreatic carcinoma cell growth by autocrine regulation. Cancer. Sep2002;95(6):1206-14.
30. Soni KB, et al. Effect of Oral Curcumin Administration on Serum Peroxides and Cholesterol Levels in Human Volunteers. Indian J Physiol Pharmacol. Oct1992;36(4):273-75.
31. Sharma OP. Antioxidant Activity of Curcumin and Related Compounds. Biochem Pharmacol. 1976;46:1013.
32. Natarajan C, Bright JJ Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes. J Immunol. 2002 Jun 15;168(12):65061329.
33. Kim SY, Jung SH. Kim HS. Curcumin is a potent broad spectrum inhibitor of matrix metalloproteinase gene expression in human astroglioma cells. Biochem Biophys Res Commun. 2005 Nov 18;337(2):510-6. Epub 2005 Sep 21.
34. Danilenko M, Studzinski GP.. Enhancement by other compounds of the anti-cancer activity of vitamin D(3) and its analogs. Exp Cell Res. 2004 Aug 15;298(2):339-58.
35. Sharma RA, McLelland HR, Hill KA, et al. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res 2001;7:1894-900.
36. Zhang F, Altorki NK, Mestre JR, et al. Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells. Carcinogenesis 1999;20:445-51.
37. Surh YJ. Anti-tumor promoting potential of selected spice ingredients with antioxidative and antiinflammatory activities: a short review. Food Chem Toxicol 2002;40:1091-7.
38. Miquel J, Bernd A, The curcuma antioxidants: pharmacological effects and prospects for future clinical use. A review. Arch Gerontol Geriatr. 2002 Feb;34(1):37-46. 39. Deeb D, Xu YX, Jiang H, et al. Curcumin (diferuloyl-methane) enhances tumor necrosis factor-related apoptosis-inducing ligandinduced apoptosis in LNCaP prostate cancer cells. Mol Cancer Ther 2003;2:95-103.